Director, Risk Evaluation and Mitigation Strategies - Amneal Pharmaceuticals
Kal Elhoregy is an accomplished healthcare industry executive with 23+ years’ experience focused on implementation of Risk Minimization Programs , Quality Management Systems and Pharmacovigilance Compliance for companies within the pharmaceutical industry.In his current role as a Director, Risk Evaluation and Mitigation Strategy (REMS), Regulatory Affairs Clinical at Amneal Pharmaceuticals, he manages all REMS activities for multiple programs including operations and development of new programs and ensures the entity’s full compliance with the regulatory requirement and risk management standards and guidelines.
Subscribe today to receive news on latest updates,
offers and upcoming conferences via email
Follow us online to stay up to date about our conferences